Diabetes

Tofogliflozin most effective with high baseline insulin

(HealthDay)—The sodium glucose co-transporter 2 inhibitor tofogliflozin is effective for reducing fasting plasma glucose and body weight, particularly in patients with a high insulin level at baseline, according to a study ...

Cardiology

Plasma catecholamines predict post-op A-fib after cardiac Sx

(HealthDay)—Assessment of plasma catecholamines on the morning of surgery can predict the likelihood of postoperative atrial fibrillation (POAF) for patients undergoing elective cardiac surgery, according to a study published ...

Alzheimer's disease & dementia

Investigating plasma levels as a biomarker for Alzheimer's disease

A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain ...

Diabetes

Review compares outcomes, safety for once-weekly GLP-1RAs

(HealthDay)—Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) treatments, according to a review published online Dec. 8 in the Annals of Internal Medicine.

Diseases, Conditions, Syndromes

Plasma B12 levels tied to anorexia nervosa severity

(HealthDay)—In patients with anorexia nervosa, plasma levels of vitamin B12 might be an early marker of liver dysfunction and are possibly related to more severe psychopathological aspects, according to a study published ...

page 3 from 7